CapitaLand Investment Limited – Fund and lodging businesses boost growth February 27, 2023 581

PSR Recommendation: ACCUMULATE Status: Maintained
Last Close Price: 2.51 Target Price: 4.12
  • FY22 revenue of S$2,867mn (+25% YoY) was slightly below our estimates, forming 97% of our forecast.
  • RE investment revenue grew 40% YoY, driven by an occupancy recovery in the core markets, Singapore and India. Fee-related revenue was up 9% YoY, lifted by PE fund management (+26%) and lodging management (+36%) as RevPAU recovered and rose 40% YoY. Funds under management (FUM) has risen to S$88bn (FY21: S$86bn) with inflows of S$2bn in FY22, the newly launched CapitaLand China Data Centre Partners and CapitaLand China Opportunistic Partners Programme brings embedded FUM to S$96bn.
  • Maintain ACCUMULATE with an unchanged SOTP TP of S$4.12. We lower FY23e earnings by 8% as we lower property fee management revenue estimates for FY23e. Our SOTP derived TP of S$4.12 represents an upside of 10.8% and a P/E of 16x. The pick-up in travel and China’s re-opening will be immediate catalysts for CLI.

 

The Positives

 

+ Fund management fee-related revenue (+5% YoY) formed 15% of revenue. PE fees (+26%) were boosted by higher transaction-related fees, which formed 43% of PE fees, while recurring PE fees fell 10% YoY. CLI’s listed funds posted +3% and -33% growth in recurring and transaction-related fees, respectively. The decline was the result of a high base in FY21, as transactions picked up after the pandemic year in 2020. Recurring fees made up 77% of FY22 fee-related revenue.

 

+ Lodging segment recovering steadily. Lodging management fees rose 36% on recovering operating performance as well as 9.3k/2k new units turning operational in FY22/4Q22. RevPAU grew 44% as average daily rates grew 18% and portfolio occupancy increased 10%. Recovery was seen across all CLI’s key markets, except China, with the strongest RevPAU recovery in Europe (+99%) and Singapore (+72%). The group also signed 9.3k keys in 9M22, 13% more than the number of keys signed in FY21, taking the number of keys signed to 159k. CLI is on track (~99%) to meet its 2023 target of signing 160k keys.

 

+ Real estate investment business (REIB) grew 40% YoY, on the back of reopening in most of CLI’s markets, except for China. Leasing activity in India has similarly picked up with Net Property Income growing 5% on the back of physical occupancy at business parks improving to ~60% from <5% in FY21. In Singapore, NPI rose 9% due to positive rental reversion across all asset classes and occupancy increasing across sectors. For the other markets, NPI increased 9% with resilient occupancy of >90% across sectors as improved NPI across Australia, South Korea, USA and UK/Europe offset a slight decrease in NPI for Germany and Japan.

 

The Negatives

 

– China retail lagging recovery. Due to China’s zero COVID-19 policy, China has only just started to re-open after the pandemic. While tenant sales in Singapore have recovered 29.4% YoY for FY22, tenant sales in China declined 15.7%. Similarly, shopper traffic in China has declined 23.6% compared to an increase of 28.6% in Singapore. Occupancy at Chinese malls has dipped to 90% (FY21: 94%), compared to the 97% retail occupancy for Singapore.

 

– Macro-economic and geopolitical headwinds slowing fund generation and acquisition momentum. Inflation, rising interest rates and the Russia-Ukraine conflict have resulted in higher required returns for capital investors, limiting the assets eligible to seed funds. While USD-denominated capital has taken a wait-and-see approach towards RMB investments, CLI’s RMB fund management license allows it to tap local capital. However, the lockdowns and tightened restrictions in China in FY22 have impeded business discussions and delayed planned transactions.

Important Information

This report is prepared and/or distributed by Phillip Securities Research Pte Ltd ("Phillip Securities Research"), which is a holder of a financial adviser’s licence under the Financial Advisers Act, Chapter 110 in Singapore.

By receiving or reading this report, you agree to be bound by the terms and limitations set out below. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately.

The information and any analysis, forecasts, projections, expectations and opinions (collectively, the “Research”) contained in this report has been obtained from public sources which Phillip Securities Research believes to be reliable. However, Phillip Securities Research does not make any representation or warranty, express or implied that such information or Research is accurate, complete or appropriate or should be relied upon as such. Any such information or Research contained in this report is subject to change, and Phillip Securities Research shall not have any responsibility to maintain or update the information or Research made available or to supply any corrections, updates or releases in connection therewith.

Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this report are as of the date indicated and are subject to change at any time without prior notice. Past performance of any product referred to in this report is not indicative of future results.

This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This report should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own independent verification and exercise of judgment. The fact that this report has been made available constitutes neither a recommendation to enter into a particular transaction, nor a representation that any product described in this report is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may be described in this report involve significant risks and may not be suitable for all investors, and that any decision to enter into transactions involving such products should not be made, unless all such risks are understood and an independent determination has been made that such transactions would be appropriate. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete discussion of such risks.

Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any decision to purchase any product mentioned in this report should take into account existing public information, including any registered prospectus in respect of such product.

Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may provide an array of financial services to a large number of corporations in Singapore and worldwide, including but not limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting activities), brokerage or securities trading activities. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have participated in or invested in transactions with the issuer(s) of the securities mentioned in this report, and may have performed services for or solicited business from such issuers. Additionally, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have provided advice or investment services to such companies and investments or related investments, as may be mentioned in this report.

Phillip Securities Research or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report may, from time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price or income return of the investment.

To the extent permitted by law, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may at any time engage in any of the above activities as set out above or otherwise hold an interest, whether material or not, in respect of companies and investments or related investments, which may be mentioned in this report. Accordingly, information may be available to Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, which is not reflected in this report, and Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following its publication. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited its officers, directors, employees or persons involved in the issuance of this report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of this report.

The information, tools and material presented herein are not directed, intended for distribution to or use by, any person or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the applicable law or regulation or which would subject Phillip Securities Research to any registration or licensing or other requirement, or penalty for contravention of such requirements within such jurisdiction.

This report is intended for general circulation only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. The products mentioned in this report may not be suitable for all investors and a person receiving or reading this report should seek advice from a professional and financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such products, taking into account the specific investment objectives, financial situation or particular needs of that person, before making a commitment to invest in any of such products.

This report is not intended for distribution, publication to or use by any person in any jurisdiction outside of Singapore or any other jurisdiction as Phillip Securities Research may determine in its absolute discretion.

IMPORTANT DISCLOSURES FOR INCLUDED RESEARCH ANALYSES OR REPORTS OF FOREIGN RESEARCH HOUSE

Where the report contains research analyses or reports from a foreign research house, please note:

  1. recipients of the analyses or reports are to contact Phillip Securities Research (and not the relevant foreign research house) in Singapore at 250 North Bridge Road, #06-00 Raffles City Tower, Singapore 179101, telephone number +65 6533 6001, in respect of any matters arising from, or in connection with, the analyses or reports; and
  2. to the extent that the analyses or reports are delivered to and intended to be received by any person in Singapore who is not an accredited investor, expert investor or institutional investor, Phillip Securities Research accepts legal responsibility for the contents of the analyses or reports.
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

About the author

Profile photo of Glenn Thum

Glenn Thum
Research Analyst
PSR

Glenn covers the Banking and Finance sector. He has had 3 years of experience as a Credit Analyst in a Bank, where he prepared credit proposals by conducting consistent critical analysis on the business, market, country and financial information. Glenn graduated with a Bachelor of Business Management from the University of Queensland with a double major in International Business and Human Resources.

Get access to all the latest market news, reports, technical analysis
by signing up for a free account today!